After five days of deliberation, a Brooklyn jury found Martin Shkreli, the former CEO of the biotech firm Retrophin (RTRX) - Get Report as well as the founder of Turing Pharmaceuticals AG, guilty on three of eight counts of securities fraud.
Read More:Pharma Bro Martin Shkreli 'Delighted' With Verdict in Fraud Case
Watch More with TheStreet:
- 5 Ways Companies Are Using AI to Secretly Change Your Life
- Around the World in 5 Insane Pizza Hut Pizzas
- This Nissan Technology Prevents Kids From Being Left in Hot Parked Cars
- Tesla's Elon Musk Is All Jokes as the Model 3 Accelerates into "Production Hell"